LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 20.68 | 27.76 | 1669 | 1119 | 1.4915 | 1.1557 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 22.39 | 27.76 | 1315 | 1305 | 1.0071 | 1.0026 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 22.39 | 27.76 | 1397 | 1305 | 1.0699 | 1.0245 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 22.39 | 27.76 | 1653 | 1305 | 1.2660 | 1.0867 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 22.39 | 27.76 | 1792 | 1305 | 1.3724 | 1.1173 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 24.09 | 27.76 | 1415 | 1461 | 0.9681 | 0.9887 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 24.09 | 27.76 | 1480 | 1461 | 1.0126 | 1.0044 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 24.09 | 27.76 | 1737 | 1461 | 1.1884 | 1.0613 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 24.09 | 27.76 | 1870 | 1461 | 1.2794 | 1.0881 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 25.79 | 27.76 | 1461 | 1605 | 0.9102 | 0.9681 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 25.79 | 27.76 | 1512 | 1605 | 0.9420 | 0.9797 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 25.79 | 27.76 | 1865 | 1605 | 1.1619 | 1.0519 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 25.79 | 27.76 | 1960 | 1605 | 1.2211 | 1.0694 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 27.49 | 27.76 | 1498 | 1723 | 0.8693 | 0.9535 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 27.49 | 27.76 | 1523 | 1723 | 0.8839 | 0.9590 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 27.49 | 27.76 | 1959 | 1723 | 1.1369 | 1.0435 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 27.49 | 27.76 | 2051 | 1723 | 1.1903 | 1.0594 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 29.19 | 27.76 | 1611 | 1863 | 0.8647 | 0.9527 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 29.19 | 27.76 | 1642 | 1863 | 0.8813 | 0.9588 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 29.19 | 27.76 | 1945 | 1863 | 1.0439 | 1.0142 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 29.19 | 27.76 | 2016 | 1863 | 1.0820 | 1.0262 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 30.90 | 27.76 | 1605 | 2032 | 0.7897 | 0.9252 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 30.90 | 27.76 | 1628 | 2032 | 0.8010 | 0.9296 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 30.90 | 27.76 | 2216 | 2032 | 1.0904 | 1.0281 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 30.90 | 27.76 | 2287 | 2032 | 1.1253 | 1.0385 | MN20160318_Q01 | N08 |